Posts by Michael Talkowski, PhD
-
MGH Research Scholars Respond to COVID-19
This video highlights how the MGH Research Scholars rapidly mobilized to address key medical and scientific challenges posed by COVID-19.
-
First Major Study of Human Genetic Variation (gnomAD)
The Genome Aggregation Database (gnomAD) Consortium has outlined its first set of discoveries from an extensive database of exomes and genomes from populations around the world.
Biography
The Talkowski laboratory explores the impact of genomic alterations on human neurodevelopment and neuropsychiatric disorders, and the application of innovations in sequencing technology to genetic diagnostics. Mike received undergraduate degrees in Biology and Psychology and a PhD in Human Genetics with a focus in genetic epidemiology and psychiatric genetics. He joined the Center for Genomic Medicine (CGM) of Massachusetts General Hospital, the Department of Neurology in Harvard Medical School, and the Program in Medical and Population Genetics at the Broad Institute as a Postdoctoral Fellow with Dr. James Gusella in 2008 to study the genetic etiology of neurodevelopmental disorders, particularly autism spectrum disorders. He was appointed to the faculty of the CGM and Harvard Medical School in 2011. Mike’s laboratory is funded by the National Institutes of Health, the Simons Foundation for Autism Research, the Nancy Lurie Marks Family Foundation, the March of Dimes, the Charles Hood Foundation, the CHARGE Syndrome foundation, and NARSAD.
